ICH Urged to Allow for Bioaccessibility in Metal Impurities Standards
This article was originally published in The Gold Sheet
Executive Summary
The world’s leading drug regulatory authorities aim to agree in a June ICH meeting on final standards for elemental impurities like arsenic, lead, cadmium and mercury. Industry has some ideas on what they should decide.